U.S. EPA @EPA
EPA’s Hazardous Waste pharmaceuticals rule, signed in 2019, provides regulatory certainty & cost savings of up to $15 million a year by streamlining standards for managing #HazWaste pharmaceuticals in the healthcare sector. Learn more: https://t.co/ZjZRidAYoQ https://t.co/FFDatvQLJX — PolitiTweet.org